IFITM3 and COVID-19: Interestingly, IFITM1 and IFITM3 expression levels were not correlated with most clinical characteristics and comorbidities of COVID-19 patients (Supplementary Fig. S4B, C) and did not influence in-hospital complications or mortality (Supplementary Fig. S4D, E).